OVERRIDE

The Biotech Investor

How to Profit from the Coming Boom in Biotechnology

Tom Abate

Times Books

A sophisticated investor's practical tool kit for
analyzing the science, business, opportunities, and risks in the century's most promising industry
The world is entering a biotechnology boom-but only informed investors will prosper in the incredibly complex biotech business. Separating the bioengineered wheat from the chaff, San Francisco Chronicle science and technology columnist Tom Abate, one of the top objective authorities on biotech, gives investors the analytical foundation to understand the science, finances, time horizon, and technological and commercial potential of this burgeoning industry.
In The Biotech Investor, Abate provides sophisticated business analysis, guidelines for assessing company leadership, easy-to-digest reports from the labs, and indispensable investor tools and metrics. He explains how breaking news, medical conferences, U.S. Food and Drug Administration approvals, and the patent process affect investing strategies. Finally, he looks beyond medicine to review the financial opportunities presented by biotechnology advances in everything from agriculture to jean manufacturing, and shows investors how to identify "coattail" industries such as instrumentation and software development that will benefit from biotech successes.
The Biotech Investor is the comprehensive, expert source for successful and intelligent investing in one of the twenty-first century's most promising industries.


REVIEWS

Reviews from Goodreads

BACK

ABOUT THE AUTHOR

  • Tom Abate

  • Award-winning biotechnology, technology, and health care reporter Tom Abate writes the weekly BioScope column for the San Francisco Chronicle. He lives in San Leandro, California.
BACK

BUY THE BOOK

Available Formats and Book Details

The Biotech Investor

How to Profit from the Coming Boom in Biotechnology

Tom Abate

BACK

FROM THE PUBLISHER

Times Books

BACK